TAK-875 (Fasiglifam)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | TAK-875 is a potent, selective, and orally bioavailable GPR40 agonist. |
---|
Catalog Num | A11018 |
---|---|
Formula | C29H32O7S |
Molecular Weight | 524.6 |
CAS Number | 1000413-72-8 |
SMILES | CC1=C(C2=CC(COC3=CC=C([C@H](CC(O)=O)CO4)C4=C3)=CC=C2)C(C)=CC(OCCCS(C)(=O)=O)=C1 |
Synonyms | TAK875 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 92 mg/mL (172.4 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 0.5% CMC+0.25% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.06 mL | 95.31 mL | 190.62 mL |
0.5 mM | 3.81 mL | 19.06 mL | 38.12 mL |
1 mM | 1.91 mL | 9.53 mL | 19.06 mL |
5 mM | 0.38 mL | 1.91 mL | 3.81 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2